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Abstract
 
Salmonella typhimurium
 
 is a gram-negative bacterium that survives and replicates inside vacuolar
compartments of macrophages. Infection of macrophages with 
 
S
 
.
 
 typhimurium
 
 grown under
conditions allowing expression of the type III secretion system results in apoptotic death of the
 
infected cells. Here, we show that infection of bone marrow–derived macrophages (M
 
F
 
) with
 
wild-type 
 
S
 
.
 
 typhimurium 
 
14028 results in presentation of epitopes derived from a bacteria-
encoded antigen on major histocompatibility complex (MHC) class I and MHC class II mole-
cules after internalization of apoptotic M
 
F
 
 by bystander dendritic cells (DCs). In contrast, in-
fection of M
 
F
 
 with the 
 
phoP
 
 constitutive mutant strain CS022, which does not induce
apoptosis in infected M
 
F
 
, does not result in presentation of a bacteria-derived antigen by by-
stander DCs unless the infected M
 
F
 
 are induced to undergo apoptosis by treatment with li-
popolysaccharide and ATP. DCs appear to be unique in their ability to present antigens de-
rived from M
 
F
 
 induced to undergo apoptosis by 
 
Salmonella
 
, as bystander M
 
F
 
 are not capable
of presenting the bacteria-derived antigen despite the fact that they efficiently internalize the
apoptotic cells. These data suggest that apoptosis induction by bacterial infection of M
 
F
 
 may
not be a quiescent death that allows the bacteria to escape recognition by the immune system,
but rather may contribute to an antimicrobial immune response upon engulfment by by-
stander DCs.
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Introduction
 
Salmonella typhimurium
 
 is a gram-negative bacterium that
causes a self-limiting gastroenteritis in humans and typhoid-
like systemic disease in mice. The pathogen is acquired
through the ingestion of contaminated food or water and
crosses the epithelial barrier at the level of the ileum or the
colon preferentially by invading M cells (1). This cell type,
which functions to sample luminal antigens, overlies the
lymphoid follicles (2). The bacteria subvert the normal func-
tion of M cells and are taken up by inducing membrane ruf-
fling in these cells (1). After passing through M cells, the bac-
 
teria reach the subepithelial dome of the Peyer’s patch (PP)
 
1
 
and encounter an extensive network of resident macro-
phages and dendritic cells (DCs) (3, 4). Rather than being
destroyed by these phagocytes upon engulfment, 
 
Salmonella
 
has evolved several mechanisms to survive in the harsh mi-
lieu of phagosomal compartments (5) and can be cytotoxic
to macrophages by inducing apoptosis, as has been shown
in vitro (6, 7).
Apoptosis, or programmed cell death, is a process de-
fined by a distinct set of events characterized by expression
of phosphatidylserine on the cell surface, DNA fragmenta-
tion, and release of apoptotic bodies (for a review, see ref-
erence 8). Through various receptors on the cell surface of
phagocytes, apoptotic cells and bodies can be rapidly recog-
nized and engulfed, diminishing the risk of a subsequent
inflammatory response (8). It has also become evident that
 
the interaction between several genera of bacteria and phago-
cytes can lead to apoptosis (6, 7, 9–11). Recently, it has
been shown that 
 
Shigella
 
 and 
 
Salmonella
 
 induce pro-
grammed cell death through a similar mechanism, via a
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Abbreviations used in this paper:
 
 CCD, cytochalasin D; DC, dendritic
 
cell; LB, Luria broth; M
 
F
 
, bone marrow–derived macrophage(s); MHC-I
and MHC-II, MHC class I and II molecules, respectively; PI, propidium
iodide; PP, Peyer’s patch. 
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bacterial invasin that directly interacts with and activates
the proapoptotic enzyme caspase 1 (12–14). In addition,
DCs can acquire apoptotic material from influenza-infected
monocytes and stimulate MHC class I molecule (MHC-I)–
restricted CTLs (15). This suggests that apoptosis induced
by microbes can lead to an immune response rather than to
a “silent” nonimmunogenic death.
We have previously shown that macrophages and DCs
can phagocytose and process bacteria for presentation of
bacterial peptides on both MHC-I and MHC-II (16–19).
In this study, we show that DCs can also acquire apoptotic
material containing bacterial antigens from macrophages
that have undergone apoptosis caused by 
 
S
 
.
 
 typhimurium
 
 in-
fection and present epitopes from a bacteria-derived anti-
gen on both MHC-I and MHC-II. This indicates that
bacterial induction of apoptosis in phagocytes may not nec-
essarily result in a silent death, since both CD4
 
1
 
 and CD8
 
1
 
T cells can be activated.
 
Materials and Methods
 
Mice.
 
BALB/c (H-2
 
d
 
) and C57BL/6 (H-2
 
b
 
) mice were bred
in the animal facilities at Lund University or purchased from
Charles River Laboratories. Caspase 1
 
2
 
/
 
2
 
 mice (20; H-2
 
b
 
) were
provided by Manuela Baccarini, Vienna Biocenter, Vienna, Austria.
 
Bacterial Strains, Plasmids, and Growth Conditions.
 
Bacterial strains
used were 
 
S
 
.
 
 typhimurium
 
 14028s (American Type Culture Col-
lection) or its rough LPS derivative 14028r (21), the 
 
phoP
 
c
 
 mutant
CS022s (22) or its rough LPS derivative CS022r, made as described
(21). 
 
S
 
.
 
 typhimurium
 
 14028r and CS022r harbored pJLP-2H-Kan
(18), which encodes the fusion protein Crl-OVA containing res-
idues 257–277 of OVA fused near the COOH terminus of the
cytoplasmic bacterial protein Crl. The OVA fragment in Crl-
OVA contains the K
 
b
 
-binding OVA(257–264) epitope and the
I-A
 
b
 
–binding OVA(265–277) epitope. 
 
S
 
.
 
 typhimurium
 
 14028r and
CS022r containing pJLP-2H-Kan were grown in Luria broth
(LB) supplemented with 50 
 
m
 
g/ml kanamycin while 
 
S
 
.
 
 typhimu-
rium
 
 bacteria
 
 
 
not containing a plasmid were grown in LB. Bacte-
ria were grown overnight with shaking at 37
 
8
 
C. Logarithmically
growing bacteria were obtained by diluting an overnight culture
1:20 into fresh LB and incubating until the optical density at 600
nm (OD
 
600
 
)
 
 
 
reached 1.3–1.5. Bacteria were then centrifuged at
1,700 
 
g
 
 and resuspended in IMDM (without antibiotics; GIBCO
BRL) to a density of 5 
 
3
 
 10
 
8
 
 bacteria/ml. This bacterial suspen-
sion was diluted in IMDM (without antibiotics) to obtain the de-
sired amount of bacteria to be added to assays. Heat-killed and
gentamycin-treated bacteria were prepared by incubating suspen-
sions of bacteria (5 
 
3
 
 10
 
8
 
 bacteria/ml) at 65
 
8
 
C for 45 min or with
100 
 
m
 
g/ml gentamycin at 4
 
8
 
C for 90 min before addition to the
assay.
 
Bone Marrow Cultures.
 
DCs were obtained by culturing bone
marrow from C57BL/6 mice (H-2
 
b
 
) in IMDM supplemented
with 10% culture supernatant from Ag8653 myeloma cells trans-
fected with murine GM-CSF. DCs were separated from mac-
rophages in the cultures by transferring nonadherent cells to new
culture dishes containing IMDM plus GM-CSF and used on days
6–8 of culture as described (18). These nonadherent cells were
highly enriched for DCs and were typically 60–70% pure as as-
sessed by surface expression of MHC-II and CD11c by FACS
 
®
 
.
In some experiments, the cells were then further enriched for
CD11c-expressing cells (DCs) using anti-CD11c magnetic mi-
 
crobeads and a MiniMACS separation column (Miltenyi Biotec)
following the manufacturer’s protocol. The enriched population
consisted of 80–90% CD11c
 
1
 
 cells as assessed using HL3 anti-
body (PharMingen) and FACS
 
®
 
 analysis. Both of these DC pop-
ulations have a heterogeneous expression of MHC-II, CD80, and
CD86 (Svensson, M., C. Johansson, and M.J. Wick, manuscript
in preparation) and are phagocytic (18, 19), showing that the
DCs are in an intermediate stage of maturation (23). Both the
bulk culture and the CD11c-purified DC populations were used
in experiments and gave identical results.
Bone marrow–derived macrophages (M
 
F
 
) were prepared by
culturing bone marrow from BALB/c (H-2
 
d
 
) or caspase 1
 
2
 
/
 
2
 
mice (H-2
 
b
 
) in IMDM plus GM-CSF as above. After the nonad-
herent cells were removed onto new culture dishes, the strongly
adherent cell population was washed with HBSS. These adherent
cells, M
 
F
 
, were removed from the plastic with cold 10 mM
EDTA (pH 8.0), washed twice with HBSS, and used in experi-
ments. Alternatively, M
 
F
 
 were generated by expanding bone
marrow from BALB/c or caspase 1
 
2
 
/
 
2
 
 mice in IMDM supple-
mented with 30% supernatant from L929 cells. The strongly ad-
herent population, M
 
F
 
, was removed from the plastic and
washed as described for M
 
F
 
 derived from IMDM plus GM-CSF
cultures. M
 
F
 
 cultured from bone marrow using either IMDM
plus GM-CSF or IMDM plus L cell supernatant gave identical
results in apoptotic antigen presentation assays (data not shown).
 
Induction and Detection of Apoptosis.
 
M
 
F
 
 from BALB/c mice
were resuspended in IMDM containing 5% FCS (without antibi-
otics), and 10
 
6
 
 cells were seeded per well in 24-well cell culture–
treated or low adherence plates (Corning, Inc.). Bacteria were
diluted in IMDM (without antibiotics) and added to M
 
F
 
 at a
bacteria to M
 
F
 
 ratio of 5:1, 15:1, or 50:1 as indicated in individual
experiments. Bacteria were pelleted onto the cells by centrifuga-
tion at 270 
 
g
 
 for 4 min at room temperature, and the plates were
incubated for 30–120 min at 37
 
8
 
C with 5% CO
 
2
 
. The cultures
were then washed twice with HBSS to remove remaining bacte-
ria and either incubated for an additional 2 h in the presence of
100 
 
m
 
g/ml gentamycin (a total of 4 h) or the cells were directly
assessed for apoptosis by Annexin V staining at the indicated time
points. Necrotic cells were excluded by staining with propidium
iodide (PI) at 1 
 
m
 
g/ml (Sigma Chemical Co.). Incubations with
Annexin V–FITC (Trevigene, Inc.) were for 20 min on ice.
Flow cytometry analysis was performed on a Becton Dickinson
FACSort™ flow cytometer (Becton Dickinson), and data were
collected on 3 
 
3
 
 10
 
4 
 
PI
 
2
 
 cells. Apoptosis was further confirmed
by detection of high molecular weight DNA fragments as de-
scribed (24). In samples where apoptosis was chemically induced,
M
 
F
 
 were treated with 1 
 
m
 
g/ml of LPS purified from 
 
Escherichia
coli
 
 (Sigma Chemical Co.) for 4 h at 37
 
8
 
C with 5% CO
 
2
 
.
 
 
 
This was
followed by incubation with 5 mM ATP for 45 min (20).
 
Presentation of Antigens Derived from Apoptotic Material.
 
After in-
fection of M
 
F
 
 with bacteria and washing with HBSS as described
above, fresh IMDM supplemented with 5% FCS and 100 
 
m
 
g/ml
gentamycin were added and the infected M
 
F
 
 were incubated for
an additional 2 h. After an additional wash with HBSS, the M
 
F
 
were resuspended in 500 
 
m
 
l of IMDM supplemented with 10%
FCS and 50 
 
m
 
g/ml gentamycin. Then, 10
 
6 
 
DCs or M
 
F
 
, either
live or prefixed in 1% paraformaldehyde and subsequently
washed thoroughly, were added to the apoptotic M
 
F
 
 in 250 
 
m
 
l
of IMDM. This resulted in a 1:1 DC or M
 
F
 
 to apoptotic M
 
F
 
 ra-
tio. Finally, 5 
 
3
 
 10
 
5
 
 CD8OVA (17) or OT4H.2D5 (25) T hybrid-
oma cells, which secrete IL-2 upon specific recognition of the
OVA(257–264)/K
 
b
 
 or OVA(265–277)/I-A
 
b
 
 complex, respec-
tively, were added in 250 
 
m
 
l of IMDM. After a 24-h incubation 
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at 37
 
8
 
C, IL-2 secreted by the CD8OVA or OT4H.2D5 T hy-
bridoma cells was quantitated using IL-2–dependent CTLL cells.
In experiments where M
 
F
 
 from caspase 12/2 mice (H-2b) were in-
fected with bacteria, the assay was performed in the same way ex-
cept that the T hybridoma cells were not added together with the
DCs but after incubation of DCs with (apoptotic) MF as follows.
After 20 h of DC–MF coculture, cells from three wells were col-
lected and resuspended in cold PBS supplemented with 0.5%
FCS and 2 mM EDTA. The suspension was then enriched for
CD11c-expressing cells (DCs) using anti-CD11c magnetic mi-
crobeads (Miltenyi Biotec) following the manufacturer’s proto-
col. The enriched population consisted of 80–90% CD11c1 cells
as assessed using HL3 antibody (PharMingen) and FACS® analy-
sis. 105 purified CD11c1 cells were then added to duplicate wells
in a 96-well plate (Corning, Inc.) together with 105 T hybridoma
cells. Cells were coincubated for 24 h at 378C with 5% CO2, and
IL-2 produced by the T hybridoma cells was quantified as above.
Experiments where the inhibitor cytochalasin D (CCD, 5 mg/ml;
Sigma Chemical Co.) was used were also performed such that the
DCs were coincubated with MF for 20 h in the presence of
CCD followed by enrichment of CD11c1 DCs by magnetic sort-
ing. The enriched DCs were subsequently added to T hybridoma
cells in fresh wells. This was done to retain viability of the DCs
and to assure that equal amounts of viable DCs were added to the
T hybridoma cells.
Direct Presentation of Bacterial Antigens by Infected DCs. Exper-
iments to assess direct presentation of bacterial antigens by DCs
were conducted in 24-well or 96-well plates as described previ-
ously (18), except that DCs were not fixed after coincubation
with the bacteria. Instead, bacteria were coincubated with DCs at
the indicated bacteria to DC ratio for 2 h and the cells were
washed three times with HBSS. Then, fresh IMDM containing
5% FCS and 50 mg/ml gentamycin was added. This was followed
by addition of T hybridoma cells and quantitation of IL-2 pro-
duction as described for the other antigen presentation assays.
Phagocytosis of Apoptotic Cells. MF were dyed red using
PKH26-GL (Sigma Biosciences), and 106 dyed cells were coincu-
bated with 14028r or CS022r for 90 min and washed as described
above. After incubation for an additional 2 h in IMDM supple-
mented with 50 mg/ml gentamycin, 2.5 3 105 MACS-purified
DCs or MF dyed green using PKH67-GL (Sigma Biosciences)
were added to the red MF. After 2 h of coincubation, flow cy-
tometry was performed and the percentage of double positive
cells among the green cells was determined. In samples where
CCD was present, the green cells were first pretreated for 60 min
with CCD at 10 mg/ml and the concentration of CCD was
5 mg/ml during the coincubation with the red MF.
Results
DCs Acquire Antigens from MF Induced to Undergo Apopto-
sis by Salmonella Infection. Infection of MF and DCs with
S. typhimurium using conditions that do not alter the viabil-
ity of the infected cells, such as with bacteria in the station-
ary phase of growth, results in processing of the bacteria for
peptide presentation on MHC-I and MHC-II (16–19, 21).
It has also been shown that infection of MF with S. typhi-
murium grown under conditions resulting in an invasive
phenotype and expression of the type III secretion appara-
tus (6, 26, 27), such as during the logarithmic growth
phase, results in apoptotic death of infected MF (6, 7).
Thus, we sought to determine whether S. typhimurium–
induced apoptosis of infected MF was a quiescent death
that did not result in presentation of bacterial antigens to T
cells, or whether bystander APCs could acquire bacterial
antigens from MF induced to undergo apoptosis by S. ty-
phimurium infection. MF were infected with logarithmi-
cally growing wild-type S. typhimurium 14028r, which in-
Figure 1. Logarithmically growing S. typhimurium 14028 induces apoptosis in MF, whereas the phoPc mutant CS022 or stationary phase 14028 does
not. (a) MF were coincubated with increasing bacteria to MF ratios (5:1, 15:1, or 50:1) for 2 h. Residual bacteria were washed away, and the cells were
incubated for an additional 2 h in medium with gentamycin (100 mg/ml). The cells were stained with Annexin V–FITC and PI and were analyzed in a
flow cytometer. Histograms show 3 3 104 gated PI2 cells plotted against cell number of MF coincubated with 14028s (thick line), CS022s (dotted line),
or medium (thin line). (b) MF were coincubated with either logarithmically growing 14028r (thick line) or stationary phase (plate-grown) 14028r (dot-
ted line) at a bacteria to MF ratio of 15:1, or were incubated in medium alone (thin line). At the times indicated in the histograms, infected cells were
stained and analyzed as described in a. The induction of apoptosis in the MF was confirmed by FACS® analysis or detection of high molecular weight
DNA fragments in at least three independent experiments.616 Salmonella-induced Apoptosis and Antigen Presentation
duces apoptosis in the infected cells, or with logarithmically
growing  phoP constitutive (phoPc) strain CS022r, which
does not induce apoptosis upon infection of MF as assessed
by Annexin V staining (Fig. 1) or DNA fragmentation
(data not shown). Both bacterial strains expressed the
model antigen Crl-OVA, which is expressed in the cytosol
of the bacteria (16) and encodes the MHC-I–binding
OVA(257–264) as well as the MHC-II–binding OVA(265–
277) epitope. Conditions that resulted in Annexin V1 PI2
MF after infection with 14028r but not with CS022r (Fig.
1) resulted in OVA(257–264) presentation on the MHC-I
molecule Kb as well as OVA(265–277) presentation on the
MHC-II molecule I-Ab by bystander DCs (Fig. 2, a and d).
This presentation was observed when MF were infected
with logarithmically growing 14028r but not with logarith-
mically growing CS022r, bacteria which can and cannot
induce apoptosis in infected MF, respectively (Fig. 1). In
addition, no presentation of the OVA peptides on either
MHC-I or MHC-II by bystander DCs was observed when
MF were infected with 14028r in the stationary phase of
growth (grown on agar plates for 20 h; Fig. 2, a and d). Sta-
tionary phase wild-type S. typhimurium does not induce
apoptosis in infected MF (Fig. 1 b; references 6, 7). The
presentation observed when MF were infected with loga-
rithmically growing 14028r was not due to release of pep-
tides into the culture that bound preformed surface MHC
molecules: addition of prefixed DCs instead of viable DCs
as the bystander APCs did not result in stimulation of the
OVA(257–264)/Kb– or the OVA(265–277)/I-Ab–specific
T cell hybridomas (Fig. 2, a and d). This was the case in
spite of the enhanced ability of prefixed DCs to bind exog-
enously added OVA(257–264) or OVA(265–280) peptide
compared with viable DCs (Fig. 2, b and e). The observed
presentation was not due to presentation of the bacteria-
derived OVA peptides by infected MF. This was ensured
by using MF from a haplotype of mouse (BALB/c; H-2d)
different from that recognized by the H-2b–specific
CD8OVA and OT4H.2D5 T cell hybridomas (17, 25).
Finally, omitting addition of bystander DCs (H-2b) to
the infected MF (H-2d) resulted in a similar background
level of stimulation of the T cell hybridomas as when DCs
(H-2b) or MF (H-2b) were grown in medium only (Fig. 2,
c and f, and see Fig. 5, a–c).
OVA Peptide Presentation Is Due to Uptake of Apoptotic
Material and Not to Direct Presentation of Residual Bacteria.
Several lines of data support that the MHC-I and MHC-II
presentation shown in Fig. 2, a and d, was due to uptake of
apoptotic material and not to phagocytic processing of re-
maining bacteria by the added DCs. First, addition of sta-
tionary phase 14028r, which does not induce apoptosis in
the infected MF (Fig. 1 b; references 6 and 7), did not re-
sult in MHC-I or MHC-II presentation in the apoptotic
antigen presentation assay (Fig. 2, a and d). This is the case
despite the fact that stationary phase S. typhimurium express-
Figure 2. Viable bystander DCs acquire antigenic material from MF induced to undergo apoptosis by infection with wild-type S. typhimurium. (a and
c) OVA peptide presentation on MHC-I (Kb) and (d and f) MHC-II (I-Ab) by bystander DCs quantitated using the OVA(257–264)/Kb– or the
OVA(265–277)/I-Ab–specific T cell hybridoma CD8OVA or OT4H.2D5, respectively. MF (H-2d) were coincubated for 90 min with either stationary
phase (stat) 14028r, logarithmically growing (log) 14028r, or logarithmically growing CS022r expressing Crl-OVA as indicated. After washing and addi-
tion of gentamycin, live (1 DC) or paraformaldehyde-fixed (1 fixed DC) (H-2b) or no DCs (2 DC) and T hybridoma cells were added as indicated. (b
and e) The CD8OVA (b) or OT4H.2D5 (e) response to live or fixed DCs (H-2b) loaded with 1 nM OVA(257–264) or 100 mM OVA(265–280) pep-
tide, respectively. Counts per minute in wells where bystander DCs were omitted or where DCs or MF were incubated in medium only along with the
appropriate T cell hybridoma were typically 250–2,500. The results are representative of three to five independent experiments.617 Yrlid and Wick
ing Crl-OVA is efficiently presented when phagocytosed
by DCs (18, 19). In addition, similar amounts of the bacte-
ria were internalized by the MF. This was confirmed by
coincubating MF with logarithmically growing or station-
ary phase 14028s or logarithmically growing CS022s ex-
pressing green fluorescent protein followed by flow cytom-
etry analysis (data not shown) as described elsewhere (19).
Second, we reasoned that if the presentation observed in
the apoptotic presentation assay was due to remaining bac-
teria that were phagocytosed by the added DCs, it must be
due to gentamycin-killed bacteria remaining in the wells, as
no bacterial growth was observed during the 24-h incuba-
tion time. To directly test this possibility, bacterial suspen-
sions of 14028r and CS022r were treated with gentamycin,
equal numbers of these bacteria were added to viable DCs,
and presentation of the OVA peptides was quantitated.
This resulted in equal levels of bacterial processing by DCs
for MHC-I presentation of OVA(257–264) (Fig. 3 a) and
MHC-II presentation of OVA(265–277) (Fig. 3 b). Like-
wise, similar levels of presentation of the OVA peptides on
MHC-I and MHC-II derived from the bacteria expressing
Crl-OVA was observed if the bacteria were heat-killed be-
fore addition to DCs (Fig. 3, c and d). The similar level of
MHC-I and MHC-II presentation of OVA peptides de-
rived from gentamycin-treated or heat-killed 14028r and
CS022r expressing Crl-OVA makes it unlikely that the
presentation observed in Fig. 2, a and d, was due to phago-
cytic processing of bacteria remaining in the wells. Further-
more, viable bacterial counts from samples removed from
wells of apoptotic presentation experiments where MF
were infected with either 14028r or CS022r consistently
showed that similar quantities of 14028r and CS022r were
recovered (data not shown). Such data were obtained from
.10 individual experiments that gave apoptotic presenta-
Figure 3. DCs process residual
14028 and CS022 expressing Crl-
OVA for OVA peptide presentation
on MHC-I and MHC-II equally well.
Logarithmically growing (OD600  5
1.3–1.5) 14028r Crl-OVA or CS022r
Crl-OVA bacteria were treated with
100 mg/ml of gentamycin (a and b),
heat killed (HK) at 658C (c and d), or
were left untreated (e and f) before
coincubation with DCs for 90 min.
After several washes, OVA(257–
264)/Kb (a, c, and e) and OVA(265–
277)/I-Ab (b, d, and f) were quanti-
tated using CD8OVA and OT4H.2D5
T hybridoma cells, respectively. The
results are representative of three in-
dependent experiments.618 Salmonella-induced Apoptosis and Antigen Presentation
tion results similar to that shown in Fig. 2, a and d, despite
the fact that the absolute number of bacteria recovered var-
ied between individual experiments. In addition, OVA-
specific ELISA was performed on lysates prepared from
bacteria used in apoptotic antigen presentation assays that
gave results similar to those shown in Fig. 2, a and d, to
quantitate the level of Crl-OVA expressed in logarithmi-
cally growing 14028r and CS022r. These data consistently
showed similar levels of Crl-OVA expression in the two
bacterial strains and never exceeded a twofold difference in
relative expression, sometimes slightly greater in 14028r
and sometimes greater in CS022r. Despite this, we never
observed significant presentation of the bacteria-encoded
antigens by DCs in our apoptotic bystander assay when
MF were infected with CS022r. Finally, no presentation of
either OVA(257–264) on Kb or OVA(265–277) on I-Ab
was detected when logarithmic 14028r Crl-OVA was co-
incubated with the DCs (Fig. 3, e and f), as logarithmically
growing 14028r is cytotoxic to these cells (our unpublished
results). In contrast, logarithmically growing CS022r ex-
pressing Crl-OVA, which does not induce apoptosis in in-
fected cells (Fig. 1 a), was processed for OVA peptide pre-
sentation on both MHC-I and MHC-II by DCs (Fig. 3, e
and f). Together, these data support the notion that the
presentation observed in Fig. 2, a and d, is due to uptake of
material from MF that were induced to undergo apoptosis
by infection with wild-type S. typhimurium by bystander
DCs rather than to direct presentation of residual bacteria
in the wells by bystander DCs.
Chemical Induction of Apoptosis in MF Infected with
CSO22r Results in Presentation of Bacterial Antigens by By-
stander DCs. To determine if inducing MF to undergo
apoptosis upon phagocytosis of S. typhimurium was suffi-
cient to result in presentation of apoptotic material by by-
stander DCs, MF infected with CS022r expressing Crl-
OVA were induced to undergo apoptosis by addition of
LPS and ATP (20). This treatment induced apoptosis as as-
sessed by Annexin V staining (Fig. 4 a). Presentation of
OVA(257–264) on MHC-I as well as OVA(265–277) on
MHC-II by bystander DCs was significantly enhanced
when MF (MHC-mismatched) coincubated with logarith-
mically growing CS022r were induced to undergo apopto-
sis by treatment with LPS and ATP (Fig. 4 b).
To further investigate the role of apoptosis induction in
generating material for presentation by bystander DCs, MF
from caspase 12/2 mice (20), which were previously shown
to be resistant to the cytotoxic effects of Salmonella infec-
tion (14), were used in the apoptotic antigen presentation
assay. Although a 2-h coincubation of caspase 12/2 MF
with 14028r Crl-OVA resulted in no detectable cell death,
significant death occurred upon coincubation of 14028r
with C57BL/6 MF (Fig. 4 c). Apoptotic antigen presenta-
tion assays were performed by adding DCs to MF from ei-
ther caspase 12/2 or C57BL/6 mice that had been coincu-
Figure 4. Chemical induction of
apoptosis in MF infected with
CS022 results in MHC-I and
MHC-II presentation of bacteria-
derived antigen by bystander DCs.
(a) Histogram of flow cytometry
analysis of Annexin V–FITC binding
to 3 3 104 PI2 MF that have phago-
cytosed logarithmically growing (log)
CS022r Crl-OVA (dotted line) or
CS022r Crl-OVA and were subse-
quently treated with LPS and ATP
(thick line) or that were incubated in
medium alone (thin line). Flow cy-
tometry analysis was carried out 20 h
after the apoptosis induction. (b) OVA(257–264)/Kb and OVA(265–277)/I-Ab presentation on MHC-I and MHC-II by bystander DCs (H-2b) after co-
incubation with MF (H-2d) previously coincubated with logarithmically growing CS022r Crl-OVA and left untreated or treated with LPS plus ATP as
indicated. OVA(257–264)/Kb and OVA(265–277)/I-Ab presentation was quantitated using CD8OVA and OT4H.2D5 T hybridoma cells, respectively.
(c) Viability of MF from wild-type and caspase 12/2 mice after coincubation with logarithmically growing 14028r Crl-OVA for 90 min measured as exclu-
sion of PI staining. (d) MF derived from C57BL/6 or caspase 12/2 mice were coincubated with logarithmically growing 14028r Crl-OVA or medium only
for 90 min. After washing and addition of gentamycin, DCs were added for 24 h. The DCs were then MACS-purified using anti-CD11c magnetic beads,
and presentation of OVA(265–277) on MHC-II by the DCs was quantitated by addition of OT4H.2D5 T hybridoma cells to the MACS-purified DCs.619 Yrlid and Wick
bated with 14028r expressing Crl-OVA. In contrast to the
experiments presented above, which use MHC-mis-
matched MF for bacterial infections, MF from caspase 12/2
mice are of the correct haplotype (H-2b) to be recognized
by the OT4H.2D5 T cell hybridoma. To avoid detecting
direct presentation by caspase 12/2 or C57BL/6 MF, the
infected MF were first coincubated with the bystander
DCs (also H-2b) for 20 h. After this incubation, CD11c1
cells, i.e., the added bystander DCs, were positively se-
lected from the cultures using anti-CD11c–coated mag-
netic beads. These purified DCs were then added to wells
containing OT4H.2D5 T hybridoma cells, and presenta-
tion of OVA(265–277) on I-Ab was subsequently quanti-
tated in the absence of the caspase 12/2 or C57BL/6 MF.
These experiments showed that DCs coincubated with
MF from wild-type but not caspase 12/2 mice could
sensitize the MHC-II–restricted T cell hybridoma
(Fig. 4 d).
DCs but Not MF Present Antigens from Apoptotic Material
on MHC-I Despite the Fact that Both Cell Types Internalize
Apoptotic MF. To investigate if MF also had the capacity
to acquire antigens from bacteria-induced apoptotic MF,
experiments were performed where MF or DCs were
added as the bystander APCs. Thus, MF (MHC-mis-
matched, H-2d) were coincubated with 14028r or CS022r
expressing Crl-OVA, and either MF or DCs from
C57BL/6 mice (H-2b) were added as the bystander cells.
Quantification of OVA(257–264)/Kb presentation showed
that DCs (Fig. 5 a) but not MF (Fig. 5 b) could present the
OVA epitope on MHC-I from bacteria-encoded Crl-
Figure 5. Both MF and DCs engulf apoptotic material by a process that requires cytoskeletal rearrangement despite the fact that OVA(257–264) pre-
sentation on MHC-I is restricted to DCs. OVA(257–264) presentation on MHC-I by bystander DCs (H-2b) (a) or MF (H-2b) (b) after coincubation
with MF (H-2d) that previously phagocytosed logarithmically growing 14028r Crl-OVA or CS022r Crl-OVA. After 90 min of coincubation with bac-
teria, cells were washed, gentamycin was added, and OVA(257–264) presentation by added bystander cells was quantitated using CD8OVA T hybridoma
cells. The response of MF (H-2d) and bystander cells incubated in medium only is also shown. (c) MF (H-2d) were coincubated with logarithmically
growing 14028r Crl-OVA, CS022r Crl-OVA, or were incubated in medium only for 90 min. After washing and addition of gentamycin, DCs were
added in the absence or presence of CCD (1 CCD) for 20 h. The DCs were then MACS-purified using anti-CD11c magnetic beads, and presentation
of OVA(265–277) on MHC-II by the DCs was quantitated by addition of OT4H.2D5 T hybridoma cells to the MACS-purified DCs. The response of
MF (H-2d) and bystander DCs incubated in medium only is also shown. (d) MF dyed red were either incubated in medium only or were coincubated
with logarithmically growing 14028r or CS022r as indicated above the dot plots. These red MF were then coincubated with DCs (top) or MF (bottom)
dyed green. This coincubation was done in the absence or presence (1 CCD) of CCD as indicated. Flow cytometry analysis was then performed on 3 3
104 cells. The percentage of double positive cells among green cells is indicated in each dot plot.620 Salmonella-induced Apoptosis and Antigen Presentation
OVA. No presentation by bystander MF was observed
even at a higher bacteria to MF infection ratio (50:1).
However, the MF could present bacterial antigens on
MHC-I when stationary phase 14028r or CS022r express-
ing Crl-OVA was added directly to the cells (data not
shown).
We next investigated if the lack of presentation of anti-
gens from apoptotic material on MHC-I by bystander MF
was due to an inability of MF to engulf apoptotic material.
To test this, MF were dyed red and were coincubated
with logarithmically growing 14028r or CS022r expressing
Crl-OVA. These red MF were then coincubated with
MF or DCs that were dyed green. Flow cytometry was
subsequently used to analyze the number of double positive
cells among the green cells. These data showed that MF
and DCs efficiently internalized apoptotic material from
MF that were coincubated with 14028r. In contrast, sig-
nificantly less uptake of apoptotic material was apparent
when the red MF were coincubated with CS022r or when
they were incubated in medium alone before coincubation
with green bystander cells (Fig. 5 d). Furthermore, the up-
take of apoptotic material was inhibited when CCD was
present during the coculture (Fig. 5 d). This demonstrates
that cytoskeletal rearrangements are required for the uptake
of apoptotic material. In addition, CCD also abolished pre-
sentation of OVA(265–277) on MHC-II by bystander DCs
when it was present during the coincubation of the by-
stander DCs and the MF that had previously phagocytosed
14028r expressing Crl-OVA (Fig. 5 c). Finally, the uptake
of apoptotic material by bystander DCs after coincubation
with bacterially induced apoptotic MF was further con-
firmed by electron microscopy, showing apoptotic bodies
within DCs (data not shown).
Discussion
An increasing number of bacterial species have been
shown to induce apoptosis in phagocytes, including Yersinia
pseudotuberculosis, Shigella flexneri, and S. typhimurium (6, 7,
9, 10). Although these studies have examined the mecha-
nism underlying the observed apoptosis, none of them have
investigated if this process generates antigenic material.
Thus, this is the first demonstration that bacteria-induced
apoptosis of infected cells results in presentation of a bacte-
ria-encoded antigen on both MHC-I and MHC-II by by-
stander DCs. Apoptosis induction in infected cells is critical
for presentation of bacteria-derived material by bystander
APCs. This was demonstrated here using bacterial strains
that can or cannot induce apoptosis in infected MF, and by
chemically inducing apoptosis in MF infected with bacte-
ria that cannot themselves induce apoptosis. Interestingly, it
has been suggested that Salmonella also can induce cells to
undergo a necrotic type of cell death (28). However, con-
ditions inducing such death in infected cells, for example
using a very high bacteria to macrophage ratio, resulted in
drastic reduction of the presentation of bacteria-encoded
antigens on MHC-I by bystander DCs, whereas the pre-
sentation on MHC-II was not as dramatically affected (our
unpublished observations). These observations support the
important role of apoptosis induction for presentation of
antigenic material by bystander DCs and suggest a different
role for MHC-I versus MHC-II presentation of apoptotic
material by bystander DCs.
We also showed that the observed presentation of
epitopes to T cells after bacterial induction of apoptosis in
infected MF occurred when live DCs but not MF were
present as bystander cells, and furthermore that this presen-
tation involved active phagocytosis of antigenic material.
The mechanism underlying the ability of DCs but not MF
to present antigens derived from apoptotic material, despite
the fact that both cell types actively internalize material
from neighboring apoptotic cells, remains to be clarified. In
preliminary experiments where bystander MF were added
to bystander DCs coincubated with bacteria-induced apop-
totic MF, presentation of the bacteria-encoded antigens on
MHC-I and MHC-II was diminished. Whether the ob-
served reduction in presentation by bystander DCs in the
presence of simultaneously added bystander MF was due
to a soluble factor secreted by the macrophages or a result
of competition for the antigenic material between the DCs
and the MF remains to be determined. Interestingly, a
similar ability of bystander DCs but not MF to present an-
tigenic material from monocytes induced to undergo apop-
tosis by influenza virus infection to CD81 cytotoxic T
cells, as well as reduced presentation by bystander DCs in
the presence of added bystander MF, has also been ob-
served (15). Such differences in the ability of these different
APCs to present antigens from apoptotic material may be
due to different functions they may have in initiating an
immune response. For example, DCs are the most efficient
stimulators of naive T cells due to their extensive antigen
capture capacity before they have been exposed to anti-
genic stimuli and their enhanced antigen presentation ca-
pacity after encountering antigenic stimuli or after expo-
sure to immunomodulatory factors such as LPS or TNF-a
(for a review, see reference 29). MF, on the other hand,
are not as efficient stimulators of naive T cells as DCs. This
is due, at least in part, to low or absent expression of
MHC-II and costimulatory molecules, unless the cells are
activated by, for example, IFN-g or LPS (30, 31). MF also
have extensive antigen degradative capacity, which is im-
portant in their role in innate protection against microbes.
This latter property of MF may result in extensive degra-
dation of phagocytosed apoptotic material and concomitant
lack of antigenic peptide presentation for T cell recogni-
tion.
S. typhimurium infection naturally occurs by the oral
route. After reaching the intestine, the bacteria penetrate
into deeper tissue through M cells by inducing membrane
ruffling (1). The bacteria then pass through the epithelium
of the PP and enter the subepithelial dome. This consists of
a network of MF and DCs intermingled with CD41 T
cells and B cells from the underlying follicle (4). The po-
tential interaction of S. typhimurium with MF and DCs in
the follicle dome after oral infection, combined with the
bacteria’s ability to survive inside phagocytic cells (32) and621 Yrlid and Wick
its ability to induce apoptosis in infected MF (Fig. 1; refer-
ences 6, 7), raises the question of the significance of bacte-
ria-induced apoptosis of infected MF and its influence on
the immune response to oral Salmonella infection. Indeed,
it has been shown that apoptosis occurs in vivo during in-
fection not only with S. typhimurium, but also with Y. pseudo-
tuberculosis and S. flexneri (33, 34). Although apoptotic CD181
cells have been identified in the liver of mice infected with S.
typhimurium (35), apoptotic MF were present in the lym-
phoid follicles of the PP in a rabbit ligated ileal loop model of
S. flexneri infection (34). Furthermore, Zychlinsky et al. (34)
showed that apoptotic MF were present when virulent (ap-
optosis-inducing) S. flexneri was used, whereas no increase in
the frequency of apoptotic cells above background levels was
apparent using avirulent bacteria not capable of inducing apop-
tosis. Not only were apoptotic MF present after infection
with virulent S. flexneri, but also large lymphoid follicle cells
containing multiple apoptotic nuclei were demonstrated (34).
This suggests that these cells had phagocytosed apoptotic cells,
presumably apoptotic MF. Orogastric inoculation with Y.
pseudotuberculosis revealed Mac11 cells in spleen and mesen-
teric lymph nodes that were terminal deoxynucleotidyl trans-
ferase–mediated dUTP nick end labeling assay–positive
(TUNEL1) upon infection with wild-type bacteria (33). In
contrast, no increase in Mac11 TUNEL1 cells relative to un-
infected mice was apparent when the mice were infected
with a yopJ mutant (33). Furthermore, a yopJ mutant strain
was more readily cleared from infected mice (33). These data
suggest that apoptosis induction may contribute to spread of
the bacteria and severity of the infection. However, the yopJ
locus is also required for Yersinia-mediated inhibition of IL-8
and TNF-a expression (36), which could affect clearance of
the bacteria from the host. Thus, although three genera of
bacteria that infect hosts by penetrating the intestinal epithe-
lium and accessing the lymphoid follicles of the PPs via M
cells (37) induce apoptosis in vivo, the relative contribution of
apoptosis by itself or apoptosis induction in combination with
bacteria-mediated effects on cytokine production has not
clearly been established. However, the ability of bacterial an-
tigens to be presented to T cells from bacteria-induced apop-
totic material may be yet another factor to consider when
evaluating the influence of bacteria-induced apoptosis on the
host immune response.
Immature DCs have an extensive capacity to internalize
antigens (38), including apoptotic material (15, 39–41), for
presentation on MHC-I and MHC–II. DCs in the subepi-
thelial dome are endocytic and can process protein in vivo
for presentation to naive T cells (42). It could be envi-
sioned that when bacteria reach MF underlying the epi-
thelial layer, the cells undergo apoptosis after phagocy-
tosing the bacteria; such a scenario has been suggested for
Shigella infection (34). In this way, MF neutralize the in-
ternalized bacteria and generate apoptotic material contain-
ing bacterial antigens in a “package” that does not induce
apoptosis in a subsequently phagocytosing cell. In this
study, we have shown that apoptotic material generated by
Salmonella infection can be efficiently phagocytosed by
DCs and MF. In the case of uptake by DCs, these cells can
then present bacterial antigens on MHC-I and MHC-II.
LPS, TNF-a, IL-1b (43, 44), and uptake of apoptotic ma-
terial (40) have all been shown to induce DC maturation.
This in turn triggers enhanced surface expression of costim-
ulatory molecules and DC migration (for a review, see ref-
erence 29). In the case of Salmonella, DCs containing apop-
totic material may migrate to lymphoid organs and activate
naive T cells.
Indeed, apoptotic bodies can affect the immune system.
For example, apoptotic bodies can have an immunosup-
pressive affect by reducing secretion of the proinflamma-
tory cytokines TNF-a, IL-1b, and IL-12 by LPS-stimu-
lated monocytes (45, 46). Apoptotic cells have also been
shown to induce autoantibody production when injected
into syngeneic mice (47). The recent report by Ronchetti
et al. (48) also demonstrated that injection of apoptotic
RMA cells primes a functional tumor-specific immune re-
sponse in vivo. Furthermore, DCs but not MF pulsed with
apoptotic material prime a specific antitumor CTL response
despite the fact that MF engulf apoptotic cells in vivo (48).
MF and DCs have been suggested to use different integrin
receptors, avb3 and avb5, respectively, to phagocytose apop-
totic material (39). This may result in differences in the in-
tracellular trafficking of the phagocytosed apoptotic mate-
rial and concomitant differences in ability to present the
antigens to T cells, as has been shown for MF here and
elsewhere (15, 39). The cytokine production profile of
MF and DCs after uptake of apoptotic material has also
been shown to differ. For example, MF synthesize TGF-b
(45) and downregulate production of the proinflammatory
cytokines TNF-a, IL-1b, and IL-12 (46), whereas DCs in-
crease secretion of IL-10, TNF-a, and IL-1b (40). The dif-
ferences in cytokine profiles produced by the different
APCs as well as the differential use of receptors to phagocy-
tose apoptotic material may suggest that DCs and MF have
different functions in the clearance of apoptotic material.
Interestingly, S. flexneri apoptosis of infected MF also re-
sults in release of IL-1b in its biologically active form (49).
Although IL-1b production by MF induced to undergo
apoptosis by Salmonella infection has not yet been assessed,
it is interesting to note that a similar mechanism of apopto-
sis induction, direct binding of a homologous effector pro-
tein to caspase 1 (12–14), is responsible for Salmonella- and
Shigella-induced apoptosis of infected MF. Given the abil-
ity of apoptotic material to influence the immune response
and the vast number of different bacteria that induce apop-
tosis in infected cells, the ability to combat microbial infec-
tions and develop effective recombinant bacterial vaccines
must include understanding the relationship between mi-
crobe-induced apoptosis and antimicrobial immunity.
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